These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34553183)

  • 1. Drug susceptibility of
    Tumwebaze PK; Katairo T; Okitwi M; Byaruhanga O; Orena S; Asua V; Duvalsaint M; Legac J; Chelebieva S; Ceja FG; Rasmussen SA; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Bayles BR; Rosenthal PJ; Cooper RA
    Lancet Microbe; 2021 Sep; 2(9):e441-e449. PubMed ID: 34553183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.
    Tumwebaze PK; Conrad MD; Okitwi M; Orena S; Byaruhanga O; Katairo T; Legac J; Garg S; Giesbrecht D; Smith SR; Ceja FG; Nsobya SL; Bailey JA; Cooper RA; Rosenthal PJ
    Nat Commun; 2022 Oct; 13(1):6353. PubMed ID: 36289202
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhao W; Li X; Yang Q; Zhou L; Duan M; Pan M; Qin Y; Li X; Wang X; Zeng W; Zhao H; Sun K; Zhu W; Afrane Y; Amoah LE; Abuaku B; Duah-Quashie NO; Huang Y; Cui L; Yang Z
    Front Cell Infect Microbiol; 2022; 12():1015957. PubMed ID: 36310880
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
    Shafik SH; Richards SN; Corry B; Martin RE
    PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
    Tumwebaze P; Conrad MD; Walakira A; LeClair N; Byaruhanga O; Nakazibwe C; Kozak B; Bloome J; Okiring J; Kakuru A; Bigira V; Kapisi J; Legac J; Gut J; Cooper RA; Kamya MR; Havlir DV; Dorsey G; Greenhouse B; Nsobya SL; Rosenthal PJ
    Antimicrob Agents Chemother; 2015; 59(6):3018-30. PubMed ID: 25753626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
    Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross.
    Windle ST; Lane KD; Gadalla NB; Liu A; Mu J; Caleon RL; Rahman RS; Sá JM; Wellems TE
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():208-217. PubMed ID: 33197753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
    Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
    PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites.
    Bai Y; Zhang J; Geng J; Xu S; Deng S; Zeng W; Wang Z; Ngassa Mbenda HG; Zhang J; Li N; Wu Y; Li C; Liu H; Ruan Y; Cao Y; Yang Z; Cui L
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):320-328. PubMed ID: 29793059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
    Fukuda N; Tachibana SI; Ikeda M; Sakurai-Yatsushiro M; Balikagala B; Katuro OT; Yamauchi M; Emoto S; Hashimoto M; Yatsushiro S; Sekihara M; Mori T; Hirai M; Opio W; Obwoya PS; Auma MA; Anywar DA; Kataoka M; Palacpac NMQ; Odongo-Aginya EI; Kimura E; Ogwang M; Horii T; Mita T
    Parasitol Int; 2021 Apr; 81():102277. PubMed ID: 33370608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).
    Gendrot M; Wague Gueye M; Tsombeng Foguim F; Madamet M; Wade KA; Bou Kounta M; Fall M; Diawara S; Benoit N; Lo G; Bercion R; Amalvict R; Mosnier J; Fall B; Briolant S; Diatta B; Pradines B
    Acta Trop; 2019 Aug; 196():126-134. PubMed ID: 31108084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.